Donghui Bao, Ph.D.

Scientist III

Bao is a research scientist in the Chemistry Department at Southern Research. His main research interests are ADME, drug metabolism and pharmacokinetics, and bioanalytical chemistry.

Bao received a doctorate in chemistry from Rutgers University, after which he completed a two-year, post-doctoral study at Pfizer Inc. (formerly Parke-Davis). Before joining Southern Research in 2014, he held research & development positions at several pharmaceutical companies, including Wyeth, Cumbre, and Pharmasset, where he contributed to the discovery/development of Sofosbuvir (PSI-7977) and several other compounds that went into clinical trials.

Related Articles

Southern Research breaks ground on new biotech center and campus renovations

May 16, 2022

Birmingham, Ala. – Southern Research today broke ground on a flagship biotech center that will anchor the development of 200,000 square feet of new or renovated wet lab space for life sciences. The new facility, located on the corner of Richa...
Read More

Southern Research expands, diversifies board of directors

April 27, 2022

The Southern Research board of directors has expanded to 15 members, with new additions representing a diverse range of national expertise. The new members were recently approved by the University of Alabama System Board of Trustees and will join the current board in May 2022. “S...
Read More

Southern Research Recognizes 2018 President’s Award and Excellence Awards Winners

November 21, 2018

Southern Research honored winners of its 2018 Employee Excellence Awards in a program last week. The winners include 24 individuals and five teams across technical and administrative staff and represent Southern Research’s diverse divisions and departments. All have shown a deep commitm...
Read More